1,235
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Low 30-day mortality and low carbapenem-resistance in a decade of Acinetobacter bacteraemia in South Sweden

ORCID Icon, , , , ORCID Icon, & ORCID Icon show all
Article: 2009324 | Received 26 Aug 2021, Accepted 18 Nov 2021, Published online: 10 Dec 2021

References

  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):1–9.
  • Nemec A. Classification and nomenclature of species in the genus Acinetobacter. https://apps.szu.cz/anemec/Classification.pdf
  • Wong D, Nielsen TB, Bonomo RA, et al. Clinical and pathophysiological overview of acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30(1):409–447.
  • Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358(12):1271–1281.
  • European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2018. Stockholm. 2019.
  • Nichols L. Death from pan-resistant superbug. Autops Case Rep. 2019;9(3):e2019106.
  • Befolkning i Skåne. 2020. Region Skåne. Cited 2020 Apr 08. Available from: https://utveckling.skane.se/digitala-rapporter/huga/befolkning/
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Royal College of Physicians. National Early Warning Score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. Updated report of a working party. London. 2017.
  • Solevag AL, Eggen EH, Schroder J, et al. Use of a modified pediatric early warning score in a department of pediatric and adolescent medicine. PLoS One. 2013;8(8):e72534.
  • Dickstein Y, Lellouche J, Ben Dalak Amar M, et al. Treatment outcomes of colistin- and carbapenem-resistant acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial. Clin Infect Dis. 2019;69(5):769–776.
  • 2017 Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics (World Health Organization)
  • International tourism, number of arrivals. 2020. The World Bank. Cited 2020 Apr 23. Available from. https://data.worldbank.org/indicator/st.int.arvl?end=2018&start=2009
  • Poulikakos P, Tansarli GS, Falagas ME. Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review. Eur J Clin Microbiol Infect Dis. 2014;33(10):1675–1685.
  • Du X, Xu X, Yao J, et al. Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis. Am J Infect Control. 2019;47(9):1140–1145.
  • Lee Y, Lee YT, Wang YC, et al. Risk of mortality of catheter-related bloodstream infections caused by acinetobacter species: is early removal of the catheters associated with a better survival outcome? J Intensive Care Med. 2018;33(6):361–369.
  • Holmbom M, Moller V, Nilsson LE, et al. Low incidence of antibiotic-resistant bacteria in south-east Sweden: an epidemiologic study on 9268 cases of bloodstream infection. PLoS One. 2020;15(3):e0230501.
  • Lee YT, Kuo SC, Yang SP, et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis. 2012;55(2):209–215.
  • Kuo SC, Lee YT, Yang SP, et al. Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia. Clin Microbiol Infect. 2013;19(7):634–639.
  • Lemos EV, de La Hoz FP, Einarson TR, et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect. 2014;20(5):416–423.
  • Berlau J, Aucken H, Malnick H, et al. Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Infect Dis. 1999;18(3):179–183.
  • Patil JR, Chopade BA. Distribution and in vitro antimicrobial susceptibility of Acinetobacter species on the skin of healthy humans. Natl Med J India. 2001;14(4):204–208.
  • Dijkshoorn L, van Aken E, Shunburne L, et al. Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals. Clin Microbiol Infect. 2005;11(4):329–332.
  • Antunes LC, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014;71(3):292–301.